Distributed Bio is engineering a transformative pipeline of universal vaccines and monoclonal antibody therapeutics in major areas of unmet need. Our proprietary Centivax technology enables vaccines against rapidly mutating pathogens such as influenza, HIV, and the flaviviruses. We have leveraged the unique ability of our SuperHuman2.0 antibody discovery technology to generate thousands of best-in-class molecules against 26 critical immune oncology and neurodegeneration targets, enabling our partners to save years of research time. By combining our Tumbler technology and Machine Learning, we bioengineer an internal portfolio of antibodies to address uniquely challenging therapeutic opportunities
Distributed Bio Address
201 Gateway Blvd South San Francisco, CA United States